Cart
0

Over the Counter (OTC) Drugs & Dietary Supplements Market by Category (Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Botanicals, Antacids, Smoking Cessation Products, Feminine Care, and Others), Dosage Form (Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, and Others), Product (Branded, and Generic Drugs), and Distribution Channel [Pharmacies, Grocery Stores, Vitamin and Health Food Stores, Online Pharmacies, and Others] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_172695
Pages: 220
Aug 2017 | 3110 Views
 
Author's : Garima Chandra & Suraj Sajeev
Tables: 73
Charts: 62
 

Over the Counter (OTC) Drugs & Dietary Supplements Market Overview:

Global Over The Counter (OTC) Drugs & Dietary Supplements Market was valued at $223 billion in 2016, and is expected to reach $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023. OTC drugs are also known as non-prescription medicines, as these can be availed without prescriptions. OTC medicines are safe if they are administered according to the instructions provided by healthcare professionals. However, dietary supplements contain dietary ingredients, which are used to provide nutrients to the body to fulfill the nutrient balance of the body. In addition, they provide non-nutrient chemicals, which provide biological benefit to the body.

The global over the counter drugs & dietary supplements market is driven by growth in awareness related to general health concerns and advancements in healthcare and pharmaceutical industries. In addition, growing trend among individuals to select OTC drugs for minor diseases supplements the market growth. Furthermore, stringent regulations by the FDA related to the safety and efficacy of OTC drugs hamper the market growth.

The global over the counter drugs & dietary supplements market is segmented based on category, dosage form, product, distribution channel, and geography. Based on category, it is divided into vitamin & dietary supplements, cough & cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, botanicals, antacids, smoking cessation products, feminine care, and others. Based on dosage form, it is classified into tablets, hard capsules, powders, ointments, soft capsules, liquids, and others. Based on product type, it is categorized into branded and generic drugs. On the basis of distribution channel, it is divided into pharmacies, grocery stores, vitamin & health food stores, online pharmacies, and others.

Global Over the Counter Drugs (OTC) & Dietary Supplements Market Segmentation

GLOBAL OVER THE COUNTER OTC DRUGS AND DIETARY SUPPLEMENTS MARKET SEGMENTATION

Get more information on this report : Request Sample Pages

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The vitamins and dietary supplements segment occupied the maximum market share in 2016, and is expected to maintain this trend during the forecast period, owing to rise in awareness about dietary supplements and their nutritional value for wellness. The soft capsules segment is expected to grow at the highest CAGR of 6.6% during the forecast period.

Drivers, Restraints, and Opportunities

The global market is driven by growing demand for personalized medicine for treating minor ailments and introduction of treatment protocols by healthcare payers. However, strict government regulations by the governing bodies and less awareness among individuals are expected to restrict the market growth. In addition, increase in R&D expenditure coupled with funding from the public & private sector is expected to provide lucrative growth opportunities to the market.

Market Dynamics: Drivers & Restraints

OVER THE COUNTER OTC DRUGS AND DIETARY SUPPLEMENTS MARKET MARKET DYNAMICS DRIVERS AND RESTRAINTS

Get more information on this report : Request Sample Pages

China Over The Counter (OTC) Drugs & Dietary Supplements

The rise in awareness towards personal care and treatment drives the market growth in China. In addition, increase in geriatric population along with the growing incidence of new diseases in this country is expected to supplement the market growth in the near future in China.

The report provides a comprehensive analysis of the key players operating in the global market such as Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, and AstraZeneca plc.

The other players in the value chain include Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., and The Colgate-Palmolive Company.

Key Benefits

  • The study provides an in-depth analysis of the global over the counter (OTC) drugs & dietary supplements market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A quantitative analysis from 2016 to 2023 is discussed to enable stakeholders to capitalize on the prevailing market opportunities.
  • Key market players are profiled and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
  • Porters five forces model is expected to interpret the impact of bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players on the market growth.

Over the Counter (OTC) Drugs & Dietary Supplements Market Key Segments:

By Category

  • Vitamin & Dietary Supplements
  • Cough & Cold Products
  • Analgesics
  • Gastrointestinal Products
  • Sleep Aids
  • Otic Products
  • Wart Removers
  • Mouth Care Products
  • Ophthalmic Products
  • Botanicals
  • Antacids
  • Smoking Cessation Products
  • Feminine Care
  • Others

By Dosage Form

  • Tablets
  • Hard Capsules
  • Powders
  • Ointments
  • Soft Capsules
  • Liquids
  • Others

By Product

  • Branded Drugs
  • Generic Drugs

By Distribution Channel

  • Pharmacies
  • Grocery Stores
  • Vitamin and Health Food Stores
  • Online Pharmacy
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Turkey
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Improvement in lifestyle and age related diseases
3.6.1.2. The rise in self-directed consumer
3.6.1.3. Growing awareness regarding general health concerns and advancements in healthcare industry

3.6.2. Restraints

3.6.2.1. Stringent regulatory policies by governing bodies
3.6.2.2. Lack of seamless reclassification of drugs from prescription medicines to over the counter drugs

3.6.3. Opportunities

3.6.3.1. Increasing R&D expenditure and funding from the public & private sector

Chapter: 4 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. VITAMIN AND DIETARY SUPPLEMENTS (VDS)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. COUGH & COLD PRODUCTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. ANALGESICS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. GASTROINTESTINAL PRODUCTS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. SLEEP AIDS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTIC PRODUCTS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

4.8. WART REMOVERS

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast

4.9. MOUTH CARE PRODUCTS

4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast

4.10. OPHTHALMIC PRODUCTS

4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast

4.11. BOTANICALS

4.11.1. Key market trends
4.11.2. Growth factors and opportunities
4.11.3. Market size and forecast

4.12. ANTACIDS

4.12.1. Key market trends
4.12.2. Growth factors and opportunities
4.12.3. Market size and forecast

4.13. SMOKING CESSATION PRODUCTS

4.13.1. Key market trends
4.13.2. Growth factors and opportunities
4.13.3. Market size and forecast

4.14. FEMININE CARE

4.14.1. Key market trends
4.14.2. Growth factors and opportunities
4.14.3. Market size and forecast

4.15. OTHERS

4.15.1. Key market trends
4.15.2. Growth factors and opportunities
4.15.3. Market size and forecast

Chapter: 5 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. TABLETS

5.2.1. Market size and forecast

5.3. HARD CAPSULES

5.3.1. Market size and forecast

5.4. POWDERS

5.4.1. Market size and forecast

5.5. OINTMENTS

5.5.1. Market size and forecast

5.6. SOFT CAPSULES

5.6.1. Market size and forecast

5.7. LIQUIDS

5.7.1. Market size and forecast

5.8. OTHERS

5.8.1. Market size and forecast

Chapter: 6 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS, BY PRODUCT TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. BRANDED

6.2.1. Market size and forecast

6.3. GENERICS

6.3.1. Market size and forecast

Chapter: 7 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. PHARMACIES

7.2.1. Market size and forecast

7.3. VITAMIN AND HEALTH FOOD STORES

7.3.1. Market size and forecast

7.4. ONLINE PHARMACY

7.4.1. Market size and forecast

7.5. GROCERY STORES

7.5.1. Market size and forecast

7.6. OTHERS

7.6.1. Market size and forecast

Chapter: 8 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. India market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Argentina market size and forecast
8.5.3.3. Turkey market size and forecast
8.5.3.4. Saudi Arabia market size and forecast
8.5.3.5. South Africa market size and forecast
8.5.3.6. Rest of LAMEA market size and forecast

Chapter: 9 COMPANY PROFILES

9.1. PFIZER INC.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. NOVARTIS INTERNATIONAL AG

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments

9.3. ROCHE HOLDING AG

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments

9.4. MERCK & CO., INC.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments

9.5. SANOFI S.A

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. JOHNSON & JOHNSON

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. GILEAD SCIENCES

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments

9.8. GLAXOSMITHKLINE PLC

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments

9.9. BAYER HEALTHCARE AG

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. ASTRAZENECA PLC

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 2. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND DIETARY SUPPLEMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR COUGH AND COLD PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANALGESICS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GASTROINTESTINAL PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SLEEP AIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR WART REMOVERS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR MOUTH CARE PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OPHTHALMIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BOTANICALS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANTACIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SMOKING CESSATION PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR FEMININE CARE, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER CATEGORIES, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 17. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR TABLETS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR HARD CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR POWDERS, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OINTMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SOFT CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR LIQUIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DOSAGE FORMS, BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL OVER THE COUNTER DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 25. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BRANDED DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GENERIC DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 28. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR PHARMACIES, BY REGION, 2016-2023 ($MILLION)
TABLE 29. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND HEALTH FOOD STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 30. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ONLINE PHARMACY, BY REGION, 2016-2023 ($MILLION)
TABLE 31. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GROCERY STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 32. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DISTRIBUTION CHANNELS, BY REGION, 2016-2023 ($MILLION)
TABLE 33. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 37. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 39. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 40. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 41. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 42. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 43. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 49. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 50. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 51. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 52. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 54. PFIZER: COMPANY SNAPSHOT
TABLE 55. PFIZER: OPERATING SEGMENTS
TABLE 56. NOVARTIS: COMPANY SNAPSHOT
TABLE 57. NOVARTIS: OPERATING SEGMENTS
TABLE 58. ROCHE: COMPANY SNAPSHOT
TABLE 59. ROCHE: OPERATING SEGMENTS
TABLE 60. MERCK: COMPANY SNAPSHOT
TABLE 61. MERCK: OPERATING SEGMENTS
TABLE 62. SANOFI: COMPANY SNAPSHOT
TABLE 63. SANOFI: OPERATING SEGMENTS
TABLE 64. JOHNSON: COMPANY SNAPSHOT
TABLE 65. JOHNSON: OPERATING SEGMENTS
TABLE 66. GILEAD: COMPANY SNAPSHOT
TABLE 67. GILEAD: OPERATING SEGMENTS
TABLE 68. GSK: COMPANY SNAPSHOT
TABLE 69. GSK: OPERATING SEGMENTS
TABLE 70. BAYER: COMPANY SNAPSHOT
TABLE 71. BAYER: OPERATING SEGMENTS
TABLE 72. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 73. ASTRAZENECA: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 13. U.S. OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. AUSTRALIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 28. ARGENTINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SAUDI ARABIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 31. SOUTH AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 32. REST OF LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 33. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. PFIZER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 35. PFIZER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. NOVARTIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. NOVARTIS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. NOVARTIS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. ROCHE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. ROCHE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. SANOFI: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. SANOFI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. SANOFI: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. JOHNSON: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. JOHNSON: REVENUE BY SEGMENT, 2016 (%)
FIGURE 50. JOHNSON: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. GILEAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 52. GILEAD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 53. GILEAD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. GSK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. GSK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. BAYER: NET SALES, 2014-2016 ($MILLION)
FIGURE 58. BAYER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 59. BAYER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 60. ASTRAZENECA: NET SALES, 2014-2016 ($MILLION)
FIGURE 61. ASTRAZENECA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 62. ASTRAZENECA: REVENUE BY GEOGRAPHY, 2016 (%)

 

Over the counter (OTC) drugs & dietary supplements are non-prescription medicines that can be availed from any pharmacy, health store, or via online channel. OTC drugs are not regulated based on the active pharmaceutical ingredients (API) rather than the end product.  Dietary supplements are for those individuals who have a lack of appetite or those who suffer from deficiency disorders, such as vitamin and mineral deficiency, among other deficiency disorders. Hence, OTC drugs have revolutionized the healthcare and pharmaceutical sectors, as several prescription medicines have switched to OTC medicines. This switch from prescription to non-prescription drugs is more convenient for individuals especially in the developing economies for easy accessibility of medicines as per their requirement.

Common ailments, such as cold & cough, allergies, dermal infections, lung diseases, and others have high incidence rates across the globe. Thus, advertisements and endorsements by several OTC drug manufacturing giants have increased for the treatment of related ailments in the recent years. These OTC drugs are cost-effective, and are available in a variety of forms such as powder, tablets, capsules, ointments, and others.

The factors, such as increase in awareness about the advancements in pharmaceutical industry and general health concerns coupled with rising trend among individuals for self-management of medication boost the market growth. However, stringent regulations by FDA and other governing bodies have delayed the drug approval, which further impede the market growth. In addition, lack of seamless reclassification of drugs from prescription to OTC restricts the market growth. Moreover, various key players have undertaken R&D activities to enhance OTC drugs for the treatment of various ailments, such as laxatives, oral antiseptics, analgesics, and anti-smoking products, thereby creating more opportunities for market players.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Over the Counter (OTC) Drugs & Dietary Supplements Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo